Stock request for TransMedics Group Inc - TMDX
TransMedics is a medical device company founded to address the unmet need for more and better organs for transplantation. The company has developed the Organ Care System, a first-in-class technology with the potential to improve outcomes for transplant patients and to dramatically increase the number of transplantable organs worldwide.
4-Nov-19 Market Cap (USD) $412 million
Figures to 29-Jun-19
- Total current assets $116.1 million
- Total liabilities $49.9 million
- Net loss for quarter $9.2 million
For me, the statistics around donated organ usage are shocking:
I originally heard about the share on The Motley Fool’s Industry Focus podcast, well worth a listen if you’re interested in this company.